← Leaderboards
Changying Jiang
University Of Tx Md Anderson Can Ctr
$208,272
Attributed
$416,543
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $227.2K · FY2020–21$250K$187.5K$125K$62.5K$0
'20
'21
Funding mix
By agency
NIH$416,543 · 1
By mechanism
R21$416,543 · 1
Top collaborators
- Michael Wang2 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Michael Richard Green$8,960,138
- Katy Rezvani$10,195,970
- Michael Wang$3,493,311
- Kapil N. Bhalla$16,921,043
- Rafet Basar$1,227,277
Others in their field
Other Emerging Leaders on “S Lymphoma”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$22,138,591
- Leonard Freedman · Leidos Biomedical Research, Inc.$10,332,151
- Kathleen Nicol · Research Inst Nationwide Children'S Hosp$7,187,946
- Javeed Iqbal · University Of Nebraska Medical Center$5,566,166
- John Karijolich · Vanderbilt University Medical Center$5,446,739
Research focus
S LymphomaBaseCleaved CellAlternative TreatmentB-Cell LymphomasBcl10 GeneBcl2 GeneBindingBiochemicalBiologicalB Lymphoid MalignancyCell LineCellsChronic Lymphocytic LeukemiaB-Cell ActivationClinicComplexCrispr/Cas TechnologyDisease ProgressionDrug ResistanceDrug SensitivityEffective TherapyEnzymesAgammaglobulinaemia Tyrosine Kinase